Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.

Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW, Taaffe DR, Launer LJ, White LR.

Arch Gen Psychiatry. 2008 Aug;65(8):906-12. doi: 10.1001/archpsyc.65.8.906.

2.

Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.

Beydoun MA, Beydoun HA, Kaufman JS, An Y, Resnick SM, O'Brien R, Ferrucci L, Zonderman AB.

J Am Geriatr Soc. 2013 Apr;61(4):525-34. doi: 10.1111/jgs.12156.

3.

Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA.

JAMA Neurol. 2013 Dec;70(12):1544-51. doi: 10.1001/jamaneurol.2013.4215.

4.

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.

Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ.

Arch Neurol. 2008 Jan;65(1):89-93. doi: 10.1001/archneurol.2007.29.

PMID:
18195144
5.

A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden.

Skoog I, Waern M, Duberstein P, Blennow K, Zetterberg H, Börjesson-Hanson A, Östling S, Guo X, Kern J, Gustafson D, Gudmundsson P, Marlow T, Kern S.

Biol Psychiatry. 2015 Nov 15;78(10):730-6. doi: 10.1016/j.biopsych.2015.01.006.

PMID:
25708227
6.

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.

Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1149-56. doi: 10.1136/jnnp.2010.231555.

PMID:
21493755
7.

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM.

JAMA. 1997 Oct 22-29;278(16):1349-56.

PMID:
9343467
8.

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.

Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Neurobiol Aging. 2014 Sep;35(9):2096-106. doi: 10.1016/j.neurobiolaging.2014.03.006.

9.

Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.

Rajan KB, Wilson RS, Skarupski KA, Mendes de Leon CF, Evans DA.

Psychosom Med. 2014 Feb;76(2):101-8. doi: 10.1097/PSY.0000000000000029.

10.

Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish brain power initiative.

Wang HX, Gustafson DR, Kivipelto M, Pedersen NL, Skoog I, Windblad B, Fratiglioni L.

Neurobiol Aging. 2012 May;33(5):1007.e1-7. doi: 10.1016/j.neurobiolaging.2011.10.003.

PMID:
22056199
11.

Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.

Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.

Arch Neurol. 2006 Nov;63(11):1586-90.

PMID:
17101827
12.

Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.

Corrada MM, Paganini-Hill A, Berlau DJ, Kawas CH.

Alzheimers Dement. 2013 Jan;9(1):12-8. doi: 10.1016/j.jalz.2011.12.004.

13.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702.

PMID:
23146133
14.

Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.

Traykov L, Bayle AC, Latour F, Lenoir H, Seux ML, Hanon O, Péquignot R, Bert P, Moulin F, Cantegreil I, Wenisch E, Batouche F, Mehrabian S, Rotrou Jd, Rigaud AS.

J Neurol Sci. 2007 Jun 15;257(1-2):280-3.

PMID:
17337010
15.

APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.

Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L.

Arch Neurol. 2004 Dec;61(12):1930-4. Erratum in: Arch Neurol. 2005 Mar;62(3):453.

PMID:
15596614
16.

Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease.

Bretsky PM, Buckwalter JG, Seeman TE, Miller CA, Poirier J, Schellenberg GD, Finch CE, Henderson VW.

Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13(4):216-21.

PMID:
10609670
17.

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Langbaum JB, Chen K, Caselli RJ, Lee W, Reschke C, Bandy D, Alexander GE, Burns CM, Kaszniak AW, Reeder SA, Corneveaux JJ, Allen AN, Pruzin J, Huentelman MJ, Fleisher AS, Reiman EM.

Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30.

18.

APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.

Niti M, Yap KB, Kua EH, Ng TP.

J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):306-11. doi: 10.1093/gerona/gln013.

19.

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.

Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L, Tycko B, Mayeux R.

JAMA. 1998 Mar 11;279(10):751-5.

PMID:
9508150
20.

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; Alzheimer’s Disease Neuroimaging Initiative..

JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.

PMID:
25162367
Items per page

Supplemental Content

Support Center